Ngā Mate Pāwera Manawa kua Whakakotahitia
Ingoa hua
Kete Kimi Whakakotahi mō ngā Mate Manawa HWTS-RT158A (PCR Whakapūngao)
Tiwhikete
CE
Te mate urutā
Te Mate Huaketo Korona 2019, e kiia nei ko'COVID-19', e pā ana ki te niumōnia i puta mai i te mate 2019-nCoV. Ko te 2019-nCoV he mate korona nō te momo β. He mate hopuhopu manawa whakapeka te COVID-19, ā, he ngāwari te nuinga o te iwi ki te pangia. I tēnei wā, ko te pūtake o te mate ko ngā tūroro kua pangia e te 2019-nCoV, ā, ko ngā tāngata kāore he tohu o te mate ka noho hei pūtake o te mate. E ai ki ngā rangahau mate urutā o nāianei, ko te wā whakatipu he 1-14 ngā rā, ko te nuinga he 3-7 ngā rā. Ko te kirika, te maremare maroke me te ngenge ngā āhuatanga matua. He iti noa ngā tūroro i pāngia e ngā tohu pēnei i te ihu pupuhi, te ihu pupuhi, te korokoro mamae, te mamae o te uaua me te mate korere, me ētahi atu.
Ko te rewharewha, e mōhiotia whānuitia ana ko te "rewharewha", he mate hopuhopu manawa whakapeka i puta mai i te huaketo rewharewha. He tino hopuhopu. Ka horapa te nuinga mā te maremare me te tihe. Ka puta i te puna me te takurua. E toru ngā momo o ngā huaketo rewharewha: rewharewha A (IFV A), rewharewha B (IFV B), me te rewharewha C (IFV C), ā, e toru ngā momo o te huaketo piri, e mate ai te tangata, ko te nuinga o ngā huaketo rewharewha A me te B, he huaketo RNA kotahi-aho, he wāhanga. Ko te huaketo rewharewha A he mate manawa whakapeka, tae atu ki te H1N1, H3N2 me ētahi atu momo, e ngāwari ana ki te whakarerekētanga me te pakarutanga puta noa i te ao. Ko te "Shift" e pā ana ki te whakarerekētanga o te huaketo rewharewha A, ka puta ake he "momo iti" huaketo hou. E rua ngā momo o ngā huaketo rewharewha B, ko Yamagata me Victoria. Ko te huaketo rewharewha B anake he rerekētanga antigenic, ā, ka karo i te tirotiro me te whakakorenga a te pūnaha ārai mate tangata mā roto i tana whakarerekētanga. Heoi, he puhoi ake te tere whanaketanga o te huaketo rewharewha B i te huaketo rewharewha A tangata. Ka taea hoki e te huaketo rewharewha B te whakararu i ngā mate manawa tangata me te arahi atu ki ngā mate urutā.
Ko te huaketo respiratory syncytial (RSV) he huaketo RNA, nō te whānau paramyxoviridae. Ka horahia mā roto i ngā pata hau me te whakapā tata, ā, koia te mate matua o te mate manawa o raro i roto i ngā pēpi. Ko ngā pēpi kua pangia e te RSV ka pāngia pea e te bronchiolitis kino me te niumōnia, e pā ana ki te huango i roto i ngā tamariki. Ka pāngia ngā pēpi e ngā tohu kino, tae atu ki te kirika nui, te rhinitis, te pharyngitis me te laryngitis, ā, muri iho ko te bronchiolitis me te niumōnia. Ka raru pea ētahi tamariki mate ki te otitis media, te pleurisy me te myocarditis, me ētahi atu. Ko te mate manawa o runga te tohu matua o te mate i roto i ngā pakeke me ngā tamariki pakeke.
Hongere
| FAM | SARS-CoV-2 |
| VIC(HEX) | RSV |
| CY5 | IFV A |
| ROX | IFV B |
| Kuahara 705 | Mana Whakahaere ā-roto |
Ngā Tawhā Hangarau
| Rokiroki | -18℃ |
| Te roa o te oranga | 12 marama |
| Momo Tauira | Te ūkui waha |
| Ct | ≤38 |
| LoD | 2019-nCoV: 300 Ngā Tārua/mL Huaketo rewharewha A/Huaketo rewharewha B/Huaketo manawa syncytial: 500 Ngā Tārua/mL |
| Te motuhaketanga | a) E whakaatu ana ngā hua tauhohenga whakawhiti kāore he tauhohenga whakawhiti i waenga i te kete me te mate korona tangata SARSr-CoV, MERSr-CoV, HCoV-OC43, HCoV-229E, HCoV-HKU1, HCoV-NL63, te huaketo parainfluenza momo 1, 2, 3, rhinovirus A, B, C, chlamydia pneumoniae, human metapneumovirus, enterovirus A, B, C, D, epstein-barr huaketo, rewharewha huaketo, human cytomegalo huaketo, rotavirus, norovirus, parotitis huaketo, varicella-zoster huaketo, legionella, bordetella pertussis, haemophilus influenzae, staphylococcus aureus, streptococcus pneumoniae, streptococcus pyogenes, klebsiella pneumoniae, mycobacterium tuberculosis, smoke aspergillus, candida albicans, candida glabrata, pneumocystis jiroveci me te cryptococcus hou me te waikawa nucleic genomic tangata. b) Te āheinga ārai-whakararuraru: tīpakohia te mucin (60mg/mL), 10% (v/v) o te toto me te phenylephrine (2mg/mL), oxymetazoline (2mg/mL), te konutai pūhaumāota (tae atu ki ngā mea tiaki) (20mg/mL), beclomethasone (20mg/mL), dexamethasone (20mg/mL), flunisolide (20μg/mL), triamcinolone acetonide (2mg/mL), budesonide (2mg/mL), mometasone (2mg/mL), fluticasone (2mg/mL), histamine hydrochloride (5mg/mL), alpha interferon (800IU/mL), zanamivir (20mg/mL), ribavirin (10mg/mL), oseltamivir (60ng/mL), peramivir (1mg/mL), lopinavir (500mg/mL), ritonavir (60mg/mL), mupirocin (20mg/mL), azithromycin (1mg/mL), ceftriaxone (40μg/mL), meropenem (200mg/mL), levofloxacin (10μg/mL) me te tobramycin (0.6mg/mL) mō te whakamātautau pokanoa, ā, e whakaatu ana ngā hua kāore he tauhohenga pokanoa o ngā matū pokanoa me ngā kukū kua whakahuatia i runga ake nei ki ngā hua whakamātautau o ngā pathogens. |
| Ngā Taputapu e Pā Ana | Pūnaha PCR Wā-Tūturu BioRad CFX96 Pūnaha PCR wā-tūturu Rotor-Gene Q 5plex HRM Platform |
